PMID: 6404798May 1, 1983Paper

Lipoproteins and coronary artery disease

Hospital Practice
H A Eder

Abstract

Although a great deal has been learned about HDL as a protective factor, our understanding of the role of HDL is far less comprehensive than that of LDL. Until such knowledge is available, efforts directed at altering HDL levels must be tentative and subject to revision, as indicated by experience. There is no evidence to warrant the use of drugs whose primary effect is to raise HDL.

References

Mar 1, 1982·Clinical Science·N B Myant
Mar 1, 1982·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A D AttieD Steinberg
Mar 1, 1982·The Medical Clinics of North America·H A Eder, L I Gidez
Mar 1, 1982·The Medical Clinics of North America·S M Grundy

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.